This is something I posted on another Skool group I belong to: 𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗠𝗶𝗰𝗿𝗼𝗱𝗼𝘀𝗶𝗻𝗴, 𝗛𝗮𝗹𝗳-𝗟𝗶𝗳𝗲, 𝗮𝗻𝗱 𝗙𝗶𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 "𝗦𝘄𝗲𝗲𝘁 𝗦𝗽𝗼𝘁" 𝗳𝗼𝗿 𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲 When researching next-generation metabolic peptides, navigating dosing terminology and pharmacokinetics can get confusing fast. Here is a breakdown of how half-life, microdosing, and receptor biology intersect, along with why 4 mg is considered the key threshold for Retatrutide. 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗠𝗶𝗰𝗿𝗼𝗱𝗼𝘀𝗶𝗻𝗴? Microdosing involves using smaller, sub-standard doses and titrating up gradually rather than jumping straight to standard clinical starting doses. The goal is to: - Minimize common gastrointestinal side effects (nausea, reflux, fatigue). - Allow the autonomic nervous system to adapt smoothly. - Find the Minimum Effective Dose (MED) needed for results without over-saturating receptors. 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗛𝗮𝗹𝗳-𝗟𝗶𝗳𝗲? The elimination half-life is the time it takes for the concentration of a compound in your body to be reduced by half (50%). - Steady-State: It takes approximately 4 to 5 half-lives of consistent dosing for a compound to reach a stable equilibrium in the bloodstream. - Peak vs. Trough: The highest concentration occurs shortly after injection (Peak), while the lowest concentration occurs right before the next dose (Trough). 𝗧𝗵𝗲 𝗛𝗮𝗹𝗳-𝗟𝗶𝗳𝗲 𝗼𝗳 𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲 Retatrutide has an elimination half-life of approximately 6 days. - Because 6 days is close to a week, once-weekly administration works well, but it takes roughly 24 to 30 days (~4 weeks) of consistent dosing to achieve full steady-state blood levels. - If you change your dose, allow 3 to 4 weeks to see how your body truly responds at steady state. 𝗪𝗵𝘆 𝟰 𝗺𝗴 𝗶𝘀 𝘁𝗵𝗲 𝗠𝗶𝗻𝗶𝗺𝘂𝗺 𝗧𝗮𝗿𝗴𝗲𝘁 (𝗔𝗰𝘁𝗶𝘃𝗮𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗚𝗹𝘂𝗰𝗮𝗴𝗼𝗻 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿) Retatrutide is a triple agonist (targeting GIP, GLP-1, and Glucagon receptors), but it does not activate all three equally: - High Threshold for Glucagon: The concentration needed to activate the glucagon receptor is significantly higher (over 90 times higher than GIP) than what is needed to turn on GIP and GLP-1. - The "Dual Agonist" Trap Below 4 mg: At doses below 4 mg, you are essentially only activating the GIP and GLP-1 receptors, which mimics a dual agonist like Tirzepatide. - The 4 mg Sweet Spot: Clinical trial data shows that the distinct biological markers of glucagon activation (enhanced liver fat clearance, mild resting heart rate bump, and peripheral dysesthesia or skin tingling) first appear at 4 mg. Furthermore, at 4 mg, trial dropout rates were equivalent to placebo (~4%), delivering the full triple-receptor benefit with maximum tolerability.

I took my first dose just now. Didn't sting like I thought it would. No worse that regular saline spray from Ocean Spray.

@Michael Kenny I'll be posting soon. I also made a video but I want to run it by you first. I'll be sending you a chat with a link of the video for you to review.

I created a post for Selank here.

I am currently on week two of a Tesamorelin + Ipamorelin run (7 days a week) while also taking Retatrutide at 1.5 mg weekly. My eating window is strictly protein-focused between 7:00 AM and 2:00 PM, alongside water with LMNT electrolytes and 1–2 cups of coffee (with heavy cream, zero sugar or sweeteners). My Dosing & Timing - This is the dosing schedule I use. - Dose: Started at 1 mg daily for week 1, then bumped to 2 mg daily through week 12 (7 days a week). At the 12-week mark, I’m getting a follow-up DEXA scan to check visceral fat progress (my baseline in May showed just over 1 lb of visceral fat). - Timing: I take mine at bedtime, at least one hour before sleep. Addressing Your Meal Schedule & Retatrutide Because GH secretagogues require a low-insulin/fasted state to work effectively, food intake blunts the growth hormone pulse. Since Retatrutide delays gastric emptying: - Bedtime: If you choose night dosing like me, you will need to cut off snacking much earlier (by around 7:00–7:30 PM instead of 9:30 PM) so you have a solid 3-hour fasted window before your 10:30 PM bedtime. - Morning Alternative: If moving your evening snacks isn't practical, pin immediately at 6:30 AM upon waking and wait 30–45 minutes before having your yogurt, chicken, and coffee. Vial Math & Shelf Life (7 Days/Week) Reconstituted research-grade Tesamorelin degrades relatively quickly (roughly a 7-day stability window in the fridge). Keep that in mind when picking vial sizes to minimize waste: - At 2 mg daily for 7 days (14 mg/week total): - 20 mg vial: Using 14 mg over 7 days leaves 6 mg wasted if it degrades past Day 7. - One 10 mg + One 5 mg vial (15 mg total): Reconstituting these and using them across the 7 days results in only 1 mg of waste instead of 6 mg. Hope this helps!